Next-Generation Sequencing to Elucidate the Semen Microbiome in Male Reproductive Disorders

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2024-01, Vol.60 (1), p.25
• Main Authors: Davies, Rhianna, Minhas, Suks, Jayasena, Channa N
• Format: Article
• Language: English
• Subjects: Asymptomatic; Bacteria; Biopsy; DNA damage; Females; Fertility; High-Throughput Nucleotide Sequencing; Humans; Immune response; Infections; Infertility; Male; microbiota; Microbiota - genetics; morphology; Pregnancy; Reactive Oxygen Species; Semen; Sperm; Testes; Vagina
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina60010025

Mean sperm counts are declining at an accelerated rate and infertility is increasingly becoming a public health concern. It is now understood that human semen, previously considered to be sterile, harbours its own specific microbiome. Via activated leucocytes and the generation of reactive oxygen species, bacteria have the capability of evoking an immune response which may lead to sperm damage. Men with infertility have higher rates of both reactive oxygen species and sperm DNA damage. Due to the lack of sensitivity of routine culture and PCR-based methods, next-generation sequencing technology is being employed to characterise the seminal microbiome. There is a mounting body of studies that share a number of similarities but also a great range of conflicting findings. A lack of stringent decontamination procedures, small sample sizes and heterogeneity in other aspects of methodology makes it difficult to draw firm conclusions from these studies. However, various themes have emerged and evidence of highly conserved clusters of common bacteria can be seen. Depletion or over-representation of specific bacteria may be associated with aberrations in traditional and functional seminal parameters. Currently, the evidence is too limited to inform clinical practice and larger studies are needed.